[1] 罗龙龙,张彦,侯春梅,等.抗CD40单克隆抗体研究进展[J]. 中国实验血液学杂志,2013,21(2):508-512. [2] 吴甜,郭韧,REN G.CD40/CD40L基因及其多态性与动脉粥样硬化的研究进展[J].中南大学学报(医学版),2012,37(4): 413-418. [3] 杜振兰. CD40-CD40L共刺激途径在体液免疫和细胞免疫中的作用[J].细胞与分子免疫学杂志,2012,28(12):1341-1343. [4] CLAUDE-HENRY V,GHANIA A G,JEREMY F,et al.CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling[J]. Experimental cell research,2009,315(13):2265-2274. [5] NADEAU P J,ANNIE R,CATHERINE G S A,et al. Modulation of CD40-activated B lymphocytes by N-acetylcysteine involves decreased phosphorylation of STAT3[J]. Molecular immunology,2012,49(4):582-592. [6] 任超,葛秀国,李吉霞.鸡CD40L基因的原核表达及多克隆抗体的制备[J].黑龙江畜牧兽医,2014(7):32-36. [7] BARR T A,MCCORMICK A L,JENNIFER C,et al.A potent adjuvant effect of CD40 antibody attached to antigen[J].Immunology,2010,109(1):87-92. [8] 赵烨,刘玺,王若愚,等. CD40/CD40L系统对B淋巴细胞的作用研究进展[J].细胞与分子免疫学杂志,2015,31(5): 144-147. [9] 李向茸,马瑞仙,李倩,等.人跨膜蛋白39A原核表达载体构建、条件优化及可溶性表达[J].基础医学与临床,2019,39(7):932-936. [10] 付俊,缪时英,宋伟.人精子肌动蛋白样蛋白7a蛋白在大肠杆菌系统的表达纯化及多克隆抗体制备[J].细胞与分子免疫学杂志,2013,29(5):507-510. [11] 周宇荀,魏东芝,王二力.融合蛋白表达载体pGEX及其应用[J].生命科学,1998,10(3):122-124. [12] VINUESA C,GARCíA D E,MACLENNAN I C,et al. Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help[J].European journal of immunology, 2015,29(10):3216-3224. [13] RYCYZYN M A,STAQUET K,FISHER J,et al.The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation[J].Hybridoma,2008,27(1):25-30. [14] BARR T A,CARLRING J,HEATH A W.Co-stimulatory agonists as immunological adjuvants[J].Vaccine,2006,24(17): 3399-3407. [15] BARR T A,MCCORMICK A L,JENNIFER C,et al.A potent adjuvant effect of CD40 antibody attached to antigen[J].Immunology,2010,109(1):87-92. |